Study guide

1.1 Pathophysiology of Shock and Sepsis

Board Certified Critical Care Pharmacist Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pathophysiology and Recognition of Critical Illness

1.1 Pathophysiology of Shock and Sepsis 1.2 Respiratory Failure and ARDS Pathophysiology 1.3 ICU-Acquired Weakness and Post-Intensive Care Syndrome 1.4 Chronic Disease States and Risk Factors for Critical Illness

2 Chapter 2: Medical Devices and Circulatory Support

2.1 Hemodynamic Monitoring and Interpretation 2.2 Mechanical Circulatory Support 2.3 Mechanical Ventilation Modes and Settings 2.4 Continuous Renal Replacement Therapy 2.5 Lines, Tubes, and Drains in Critical Care

3 Chapter 3: Fluid, Electrolyte, and Acid-Base Management

3.1 Resuscitation Fluids: Crystalloids vs. Colloids 3.2 Electrolyte Disorders in the ICU 3.3 Acid-Base Disorders and Interpretation

4 Chapter 4: Vasoactive and Inotropic Therapy in Shock

4.1 Vasopressors in Distributive Shock 4.2 Inotropes and Vasopressors in Cardiogenic and Obstructive Shock

5 Chapter 5: Sedation, Analgesia, and Delirium (PADIS)

5.1 Pain and Analgesia in the ICU 5.2 Sedation Strategies and Medication Selection 5.3 Delirium Assessment, Prevention, and Treatment 5.4 Neuromuscular Blockade in Critical Illness

6 Chapter 6: Cardiovascular Emergencies

6.1 Acute Coronary Syndromes in ICU Patients 6.2 Acute Decompensated Heart Failure 6.3 Hypertensive Emergencies and Arrhythmias

7 Chapter 7: Pulmonary and Infectious Diseases in the ICU

7.1 Severe Sepsis and Septic Shock Antimicrobial Selection 7.2 Pharmacotherapy for Mechanical Ventilation and ARDS 7.3 Severe Infections in the ICU

8 Chapter 8: Neurocritical Care

8.1 Ischemic and Hemorrhagic Stroke Management 8.2 Intracranial Hypertension and Brain Edema 8.3 Status Epilepticus and Sedation in Brain Injury

9 Chapter 9: Toxicology, Endocrine, and Hematologic Emergencies

9.1 Toxicology and Antidote Therapy in the ICU 9.2 Endocrine Emergencies 9.3 Hematologic Emergencies, Anticoagulant Reversal, and Transfusions 9.4 Gastrointestinal and Hepatic Emergencies in the ICU 9.5 Dermatologic and Immunologic Conditions in the ICU 9.6 Trauma, Burns, Supportive Care, and End-of-Life Pharmacotherapy

10 Chapter 10: Special Populations, Pharmacokinetics, and Nutrition

10.1 Altered Pharmacokinetics in Critically Ill Patients 10.2 Therapeutic Drug Monitoring in the ICU 10.3 Nutrition Support: Enteral vs. Parenteral

11 Chapter 11: Quality, Safety, and Clinical Guidelines

11.1 Medication Safety and Error Prevention in the ICU 11.2 Antimicrobial Stewardship and Infection Prevention 11.3 Implementation of Clinical Practice Guidelines 11.4 Healthcare Regulations, Standards, and Drug Interactions

12 Chapter 12: Practice Management, Biostatistics, and Evidence-Based Medicine

12.1 ICU Formulary Management and Cost-Effectiveness 12.2 Biostatistics and Literature Evaluation 12.3 Clinical Trial Interpretation in Critical Care 12.4 Professional Development, Precepting, and ICU Pharmacy Services 12.5 Alternative ICU Delivery Models and Disaster Healthcare Management

13 Chapter 13: Treatment Planning and Care Coordination

13.1 Goals of Care, Perioperative Care, and Transitions of Care 13.2 Medication Delivery Routes and Devices in Critical Illness 13.3 Social Determinants of Health and Patient/Caregiver Education

1.1 Pathophysiology of Shock and Sepsis

Key Takeaways Explain This Topic AI

Shock is fundamentally a state of cellular and tissue hypoxia due to reduced oxygen delivery, increased oxygen consumption, or inadequate oxygen utilization.

The four main categories of shock are distributive (e.g., sepsis), cardiogenic, hypovolemic, and obstructive, each characterized by a distinct hemodynamic profile.

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection, primarily driven by complex inflammatory and anti-inflammatory cascades.

The initial resuscitation of septic shock requires rapid volume expansion, early administration of appropriate broad-spectrum antibiotics, and the use of vasoactive agents such as norepinephrine.

Monitoring endpoints of resuscitation, such as lactate clearance and capillary refill time, is essential for guiding ongoing therapy.

Last updated: July 2026

Pathophysiology of Shock

Shock is a life-threatening, generalized form of acute circulatory failure associated with inadequate oxygen utilization by the cells. It is a state in which cellular energy production fails to meet demand, leading to cellular dysfunction, cell death, and eventually multiorgan failure.

Cellular Hypoxia and Energy Crisis

At the cellular level, the lack of sufficient oxygen delivery (DO2) relative to consumption (VO2) forces cells to shift from aerobic metabolism (oxidative phosphorylation) to anaerobic metabolism (glycolysis). Anaerobic metabolism is highly inefficient, producing only 2 ATP molecules per glucose molecule compared to the 36-38 ATP produced aerobically. This shift leads to the accumulation of pyruvate, which is subsequently converted into lactate. The resulting lactic acidosis contributes to a lowered intracellular pH, impairing enzyme function and leading to the failure of energy-dependent ion pumps (like the Na+/K+ ATPase). As these pumps fail, cellular edema occurs, intracellular calcium levels rise, and apoptotic and necrotic pathways are triggered.

The Four Categories of Shock

Shock is traditionally classified into four distinct categories based on the primary physiologic derangement. Understanding the hemodynamic profile of each is crucial for appropriate clinical management.

Shock Category Primary Derangement Cardiac Output (CO) Systemic Vascular Resistance (SVR) Central Venous Pressure (CVP) Pulmonary Capillary Wedge Pressure (PCWP)

  • Hypovolemic Decreased preload Decreased Increased Decreased Decreased
  • Cardiogenic Pump failure Decreased Increased Increased Increased
  • Obstructive Extracardiac obstruction Decreased Increased Increased Decreased/Variable
  • Distributive Profound vasodilation Increased/Normal Decreased Decreased/Normal Decreased/Normal
  • Hypovolemic Shock

Hypovolemic shock results from a loss of intravascular volume, either through hemorrhage or non-hemorrhagic fluid loss (e.g., severe vomiting, diarrhea, burns). The reduction in circulating volume leads to decreased venous return (preload), which in turn reduces ventricular end-diastolic volume and stroke volume. The compensatory response is an increase in sympathetic tone, leading to tachycardia and severe peripheral vasoconstriction (increased SVR) to maintain blood pressure.

Cardiogenic Shock

Cardiogenic shock is characterized by the failure of the cardiac pump to deliver sufficient blood flow to the tissues, despite adequate intravascular volume. The most common cause is acute myocardial infarction. The primary insult is a profound decrease in cardiac output, which leads to increased left ventricular end-diastolic pressure (and consequently elevated PCWP). The body attempts to compensate by increasing SVR, but this often exacerbates the failing heart's workload.

Obstructive Shock

Obstructive shock occurs when there is an extracardiac physical barrier to blood flow. Common causes include massive pulmonary embolism (obstructing right ventricular outflow), tension pneumothorax, and cardiac tamponade (impeding ventricular filling). The hemodynamic profile often mimics cardiogenic shock, with low CO and high SVR, but the specific pressures (e.g., elevated CVP with normal/low PCWP in pulmonary embolism) depend on the site of obstruction.

Distributive Shock

Distributive shock is characterized by severe peripheral vasodilation and an abnormal distribution of blood flow. Sepsis is the most common cause, but anaphylaxis and neurogenic shock also fall into this category. In distributive shock, SVR is profoundly reduced. Cardiac output is typically normal or even elevated initially as a compensatory mechanism, although myocardial depression can occur in late stages.

The Pathophysiology of Sepsis

Sepsis is formally defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. When an invading pathogen (or its products, such as endotoxins or lipopolysaccharides) enters the bloodstream, it interacts with pattern recognition receptors (e.g., Toll-like receptors) on immune cells.

The Inflammatory Cascade

This interaction triggers a massive release of pro-inflammatory cytokines, including Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1 (IL-1), and Interleukin-6 (IL-6). These cytokines initiate a complex cascade that leads to:

Endothelial Dysfunction: The endothelium becomes leaky, allowing fluid and proteins to escape into the interstitial space. This exacerbates hypovolemia and impairs oxygen diffusion.

Vasodilation: Nitric oxide synthase is upregulated, producing excessive amounts of nitric oxide, a potent vasodilator. This is the primary driver of the profound drop in SVR characteristic of septic shock.

Coagulopathy: Sepsis activates the coagulation cascade while simultaneously suppressing fibrinolysis. This leads to the formation of microthrombi in small vessels (disseminated intravascular coagulation or DIC), which further obstructs blood flow and contributes to tissue ischemia and organ failure.

Organ Dysfunction

The culmination of hypoperfusion, microvascular thrombosis, and direct cellular toxicity leads to multiorgan dysfunction syndrome (MODS). The lungs are frequently affected, manifesting as Acute Respiratory Distress Syndrome (ARDS). Acute kidney injury (AKI) is common due to renal hypoperfusion and tubular injury. Hepatic dysfunction, altered mental status, and myocardial depression (septic cardiomyopathy) frequently follow.

Clinical Recognition and Initial Management

Early recognition of sepsis is paramount. While SIRS (Systemic Inflammatory Response Syndrome) criteria were previously used, the qSOFA (quick Sequential Organ Failure Assessment) score is now often utilized as a rapid bedside tool to identify patients outside the ICU at high risk for poor outcomes. A qSOFA score incorporates:

  • Respiratory rate ≥ \ge ≥ 22 breaths/min
  • Altered mentation
  • Systolic blood pressure ≤ \le ≤ 100 mmHg

The cornerstone of septic shock management is the immediate initiation of the 1-hour bundle:

Measure lactate level.

Obtain blood cultures before administering antibiotics.

Administer broad-spectrum antibiotics.

Begin rapid administration of 30 mL/kg crystalloid for hypotension or lactate ≥ \ge ≥ 4 mmol/L.

Apply vasopressors if hypotensive during or after fluid resuscitation to maintain a mean arterial pressure (MAP) ≥ \ge ≥ 65 mmHg.

Norepinephrine is the first-line vasopressor for septic shock. If the MAP target is not achieved with norepinephrine alone, vasopressin or epinephrine can be added.